TY - JOUR
T1 - Asthma and other allergic conditions in Colombia
T2 - A study in 6 cities
AU - Dennis, Rodolfo
AU - Caraballo, Luis
AU - García, Elizabeth
AU - Caballero, Andrés
AU - Aristizabal, Gustavo
AU - Córdoba, Hernán
AU - Rodriguez, Maria N.
AU - Rojas, Maria X.
AU - Orduz, Carlos
AU - Cardona, Ricardo
AU - Blanco, Arcelio
AU - Egea, Eduardo
AU - Verbel, Carlos
AU - Cala, Luz L.
N1 - Funding Information:
This study was supported by contract 298 –98 awarded by the Colombian Institute for the Development of Science and Technology (COLCIENCIAS) and by grants from Glaxo Wellcome; Astra-Zeneca; Boehringer Ingelheim; the Colombian Association of Allergy, Asthma, and Immunology; the Colombian Society of Pneumology and Thoracic Surgery; and the Colombian Society of Pediatric Pneumology.
PY - 2004/12
Y1 - 2004/12
N2 - Background: No detailed information is available on the burden and impact of allergic diseases simultaneously for adults and children in Colombia and most Latin American countries. Objectives: To investigate the prevalence of asthma, allergic rhinitis, and atopic dermatitis symptoms in 6 cities in Colombia; to measure patient expenses and school days and workdays lost; to describe disease severity; and to determine levels of total and specific IgE in asthmatic subjects. Methods: A multistage stratified random sample selection of schools with subjects aged 5 to 18 years in each city was used. Guardian subjects selected were contacted, and home visits were arranged. Subjects aged 1 to 4 years and older than 19 years were also selected randomly by systematic sampling based on the addresses of the subjects aged 5 to 18 years. Subjects with asthma symptoms were invited to provide a blood sample. Results: Information was obtained from 6,507 subjects. The prevalence of asthma, rhinitis, and atopic dermatitis symptoms in the past 12 months was 10.4% (95% confidence interval [CI], 9.7%-11.1%), 22.6% (95% CI, 21.6%-23.6%), and 3.9% (95% CI, 3.4%-4.4%), respectively. Thirty-eight percent of asthmatic subjects had visited the emergency department or have been hospitalized, and 50% reported lost school days and workdays. Seventy-six percent of sampled asthmatic patients were considered to be atopic. Conclusions: The burden of disease and societal consequences of allergic entities in urban settings in countries such as Colombia are of concern but are largely ignored, perhaps because of the misconception that these diseases are of public health importance only in industrialized nations.
AB - Background: No detailed information is available on the burden and impact of allergic diseases simultaneously for adults and children in Colombia and most Latin American countries. Objectives: To investigate the prevalence of asthma, allergic rhinitis, and atopic dermatitis symptoms in 6 cities in Colombia; to measure patient expenses and school days and workdays lost; to describe disease severity; and to determine levels of total and specific IgE in asthmatic subjects. Methods: A multistage stratified random sample selection of schools with subjects aged 5 to 18 years in each city was used. Guardian subjects selected were contacted, and home visits were arranged. Subjects aged 1 to 4 years and older than 19 years were also selected randomly by systematic sampling based on the addresses of the subjects aged 5 to 18 years. Subjects with asthma symptoms were invited to provide a blood sample. Results: Information was obtained from 6,507 subjects. The prevalence of asthma, rhinitis, and atopic dermatitis symptoms in the past 12 months was 10.4% (95% confidence interval [CI], 9.7%-11.1%), 22.6% (95% CI, 21.6%-23.6%), and 3.9% (95% CI, 3.4%-4.4%), respectively. Thirty-eight percent of asthmatic subjects had visited the emergency department or have been hospitalized, and 50% reported lost school days and workdays. Seventy-six percent of sampled asthmatic patients were considered to be atopic. Conclusions: The burden of disease and societal consequences of allergic entities in urban settings in countries such as Colombia are of concern but are largely ignored, perhaps because of the misconception that these diseases are of public health importance only in industrialized nations.
UR - http://www.scopus.com/inward/record.url?scp=10344245534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10344245534&partnerID=8YFLogxK
U2 - 10.1016/S1081-1206(10)61265-3
DO - 10.1016/S1081-1206(10)61265-3
M3 - Research Article
C2 - 15609767
AN - SCOPUS:10344245534
SN - 1081-1206
VL - 93
SP - 568
EP - 574
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 6
ER -